203 related articles for article (PubMed ID: 17541888)
1. Value and actuality of the prescription information for therapeutic drug monitoring of psychopharmaceuticals: a comparison with the medico-scientific evidence.
Ulrich S; Hiemke C; Laux G; Müller-Oerlinghausen B; Havemann-Reinecke U; Riederer P; Zernig G; Baumann P;
Pharmacopsychiatry; 2007 May; 40(3):121-7. PubMed ID: 17541888
[TBL] [Abstract][Full Text] [Related]
2. French summaries of product characteristics: content in relation to therapeutic monitoring of psychotropic drugs.
Rougemont M; Ulrich S; Hiemke C; Corruble E; Baumann P
Fundam Clin Pharmacol; 2010 Jun; 24(3):377-84. PubMed ID: 20199581
[TBL] [Abstract][Full Text] [Related]
3. The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry.
Baumann P; Hiemke C; Ulrich S; Eckermann G; Gaertner I; Gerlach M; Kuss HJ; Laux G; Müller-Oerlinghausen B; Rao ML; Riederer P; Zernig G;
Pharmacopsychiatry; 2004 Nov; 37(6):243-65. PubMed ID: 15551191
[TBL] [Abstract][Full Text] [Related]
4. AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011.
Hiemke C; Baumann P; Bergemann N; Conca A; Dietmaier O; Egberts K; Fric M; Gerlach M; Greiner C; Gründer G; Haen E; Havemann-Reinecke U; Jaquenoud Sirot E; Kirchherr H; Laux G; Lutz UC; Messer T; Müller MJ; Pfuhlmann B; Rambeck B; Riederer P; Schoppek B; Stingl J; Uhr M; Ulrich S; Waschgler R; Zernig G
Pharmacopsychiatry; 2011 Sep; 44(6):195-235. PubMed ID: 22053351
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic drug monitoring (TDM) of psychotropic drugs: a consensus guideline of the AGNP-TDM group].
Baumann P; Hiemke C; Ulrich S; Eckermann G; Kuss HL; Laux G; Müller-Oerlingenhausen B; Rao ML; Riederer P; Zernig G; ;
Rev Med Suisse; 2006 May; 2(67):1413-8, 1420-2, 1424-6. PubMed ID: 16786958
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic drug monitoring in Italian psychiatry.
Conca A; Schmidt E; Pastore M; Hiemke C; Duffy D; Giupponi G
Pharmacopsychiatry; 2011 Sep; 44(6):259-62. PubMed ID: 21959788
[TBL] [Abstract][Full Text] [Related]
7. AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011.
Hiemke C; Baumann P; Bergemann N; Conca A; Dietmaier O; Egberts K; Fric M; Gerlach M; Greiner C; Gründer G; Haen E; Havemann-Reinecke U; Jaquenoud Sirot E; Kirchherr H; Laux G; Lutz UC; Messer T; Müller MJ; Pfuhlmann B; Rambeck B; Riederer P; Schoppek B; Stingl J; Uhr M; Ulrich S; Waschgler R; Zernig G
Pharmacopsychiatry; 2011 Sep; 44(6):195-235. PubMed ID: 21969060
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic drug monitoring in child and adolescent psychiatry.
Egberts KM; Mehler-Wex C; Gerlach M
Pharmacopsychiatry; 2011 Sep; 44(6):249-53. PubMed ID: 21959786
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic drug monitoring in child and adolescent psychiatry--practical recommendations].
Gerlach M; Rothenhöfer S; Mehler-Wex C; Fegert JM; Schulz E; Wewetzer C; Warnke A
Z Kinder Jugendpsychiatr Psychother; 2006 Jan; 34(1):5-13. PubMed ID: 16485609
[TBL] [Abstract][Full Text] [Related]
10. Current status of therapeutic drug monitoring in Australia and New Zealand: a need for improved assay evaluation, best practice guidelines, and professional development.
Norris RL; Martin JH; Thompson E; Ray JE; Fullinfaw RO; Joyce D; Barras M; Jones GR; Morris RG
Ther Drug Monit; 2010 Oct; 32(5):615-23. PubMed ID: 20683393
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic monitoring of psychotropic drugs: an outline of the AGNP-TDM expert group consensus guideline.
Baumann P; Hiemke C; Ulrich S; Gaertner I; Rao ML; Eckermann G; Gerlach M; Kuss HJ; Laux G; Müller-Oerlinghausen B; Riederer P; Zernig G
Ther Drug Monit; 2004 Apr; 26(2):167-70. PubMed ID: 15228159
[TBL] [Abstract][Full Text] [Related]
12. The complexity of active metabolites in therapeutic drug monitoring of psychotropic drugs.
Hendset M; Haslemo T; Rudberg I; Refsum H; Molden E
Pharmacopsychiatry; 2006 Jul; 39(4):121-7. PubMed ID: 16871467
[TBL] [Abstract][Full Text] [Related]
13. Concentration-Effect Relationships of Psychoactive Drugs and the Problem to Calculate Therapeutic Reference Ranges.
Hiemke C
Ther Drug Monit; 2019 Apr; 41(2):174-179. PubMed ID: 30883511
[TBL] [Abstract][Full Text] [Related]
14. A Critical Commentary on the 2017 AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology.
de Leon J
Pharmacopsychiatry; 2018 Jan; 51(1-02):63-68. PubMed ID: 28922669
[TBL] [Abstract][Full Text] [Related]
15. Consensus guideline for therapeutic drug monitoring in psychiatry (2004): Bibliometric analysis of citations for the period 2004-2011.
Schäfer A; Hiemke C; Baumann P
Nord J Psychiatry; 2016; 70(3):202-7. PubMed ID: 26399163
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic drug monitoring of antidepressants--clinical aspects.
Laux G; Baumann P; Hiemke C;
J Neural Transm Suppl; 2007; (72):261-7. PubMed ID: 17982902
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic drug monitoring: clinical practice].
Widmer N; Werner D; Grouzmann E; Eap CB; Marchetti O; Fayet A; Csajka C; Decosterd LA; Buclin T
Rev Med Suisse; 2008 Jul; 4(165):1649-50, 1652-60. PubMed ID: 18767291
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic drug monitoring. Principles and practice.
Preskorn SH; Burke MJ; Fast GA
Psychiatr Clin North Am; 1993 Sep; 16(3):611-45. PubMed ID: 8415237
[TBL] [Abstract][Full Text] [Related]
19. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic drug monitoring of psychotropic drugs in China: a nationwide survey.
Guo W; Guo GX; Sun C; Zhang J; Rong Z; He J; Sun ZL; Yan F; Tang YL; Wang CY; Li WB
Ther Drug Monit; 2013 Dec; 35(6):816-22. PubMed ID: 24263641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
